The responsible person on the label
The manufacturer, packer or distributor named on the label carries most of the duties, whoever operates the plant. Foreign brands marketing in the US are covered.
Compliance, AI computed.
MoCRA requires the responsible person named on the label to register the facility, list the product with the FDA, hold adequate substantiation of safety and report serious adverse events within 15 business days. dermaGPT keeps the records, builds the substantiation from the same product record as your EU file, and tells you when a listing goes stale.
MoCRA requires outcomes rather than a defined dossier: adequate substantiation on record, accurate listings, a working adverse-event process. The evidence overlaps with the EU file; the filings do not.
The Modernization of Cosmetics Regulation Act of 2022 gave the FDA its first real inventory of the cosmetics market.
The manufacturer, packer or distributor named on the label carries most of the duties, whoever operates the plant. Foreign brands marketing in the US are covered.
Manufacturing facilities register with the FDA and every product is listed, with its ingredients, on separate renewal cycles. A reformulation, a new shade or a new product updates the listing.
Records that actually support the safety of the product, which the FDA may require access to. A well-built CPSR carries most of this weight; the reverse does not hold.
Serious adverse events are reported to the FDA within 15 business days, which needs a defined intake, triage and reporting process, not a mailbox.
The same product record that builds your EU file supplies the US substantiation; the filings and the labelling rules are handled separately.
Four steps from product record to a listed, substantiated product.
Each substance is screened against the US restrictions and the FDA's current position, at your concentration and product type.
The toxicological profiles, exposure and safety reasoning are assembled into records the FDA can be shown on request.
Facility registration and the product listing are compiled from the same record, so the ingredients on file match the ones in the product.
Listings are updated when the product changes, and serious adverse events run through a defined 15-business-day process.
The findings that come up most often, and what the record has to show instead.
Common findings
Our strengths
Verify the data behind every compliance decision.
Not just generating compliance documents: verifying the data and the evidence behind every compliance judgement.
Three reasons to choose dermaGPT
Complex regulations compiled into executable check logic.
Recalculate and cross-check to surface inconsistencies and latent problems.
Every finding traces back to the source document, page and revision.
dermaGPT in numbers
Manual report preparation
2 months per product
With dermaGPT
As fast as 10 minutes
Evidence collection and the assessor's review are separate steps; the file itself is generated in minutes.
A short walkthrough with our team, built around your formulas and the markets you sell in.
Learn how systematic AI can optimize formula performance and elevate product portfolio outcomes.